CXCL12 and acute myeloid leukemia: Substantial evidence suggests that acute myelogenous leukemia (AML)-associated BM-MSCs show reduced CXCL12 and SCF expression with reduced sinusoidal and increased arterial cell populations (Arranz et al., 2014; Baryawno et al., 2019).